Biotechnology Stocks I: Returns for ImmunityBio, Inc. (IBRX)
IBRX has no dividends.
Table and Chart of IBRX Performance
See what a $1,000 investment in IBRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| IBRX Returns | |
|---|---|
| Start Date | Aug-31-2015 |
| Start Price | $17.12 |
| End Date | Dec-06-2024 |
| End Price | $4.96 |
| # Prices | 113 |
| Min Date | Jun-28-2019 |
| Min Price | $1.02 |
| Max Date | Feb-26-2021 |
| Max Price | $32.51 |
| Total Return | -71.03% |
| Annualized Return | -12.33% |
| Current Value of $1,000 Purchase | $290 |
| Number Returns | 6,328 |
| Average Return | 61.90% |
| Number Profitable Returns | 2,675 |
| Percent Profitable Returns | 42.27% |
| Number Unprofitable Returns | 3,653 |
| Percent Unprofitable Returns | 57.73% |
| Profitable to Unprofitable Returns Ratio | 0.73 |
| IBRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -8.990 | Price to Sales | 0.00 |
| Earnings per Share | $0.0000 |
| PE Ratio | -341304000 |
| PE to Growth Ratio | None |
| Price to Book | 471.4 |
| PRICE DATA | |
| 52 Week High | $-0.429 |
| 52 Week Low | $10.53 |
| Analyst Target Price | $73.46 |
| 50-Day Moving Average | $3.1 |
| 200-Day Moving Average | $4.497 |
| FINANCIAL DATA | |
| Revenue per Share | $-0.9 |
| Revenue | $0 |
| Profit Margin | 1.1% |
| Return on Equity | -56.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
IBRX Compare Returns with S&P 500
IBRX Trendline Chart
IBRX Moving Average Chart
IBRX Stock Return Map - See Patterns of Gains and Losses
IBRX Stock Returns/Purchase Dates